Global Live Cell Imaging Market - 2022-2029

Global Live Cell Imaging Market - 2022-2029
Market Overview

Live Cell Imaging Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 8.8 % during the forecast period (2022-2029).

Live-cell imaging has revolutionized how scientists study cells, proteins, various processes and complicated molecular interactions. Using live-cell imaging techniques, researchers may view cell shapes and functions in real-time and over time. Instead of simply presenting an image of a cell's current state, live-cell imaging enables the visualization and characterization of dynamic cellular events and processes in real-time. Exploring dynamic processes, viewing the localization and mobility of particular molecules, and analyzing structural aspects of a cell are some of the most important uses of live cell imaging. Furthermore, live-cell imaging techniques enable scientists to monitor the physiological integrity of cells and other cellular and molecular processes such as exocytosis, signal transduction, enzyme activity, and protein trafficking.

Market Dynamics

The development of new technology to capture live cell images to study cell biology is expected to drive market growth.

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed a new generation of microscopes that captures 3D live-cell movies and produces considerably higher quality images, greatly improving the accuracy and scope of cell biology research. The LiTone Line Bessel Sheet (LBS) microscope developed by a team led by Prof Du Shengwang and Prof Michael Loy from HKUST, on the other hand, is 1,000 times less photo-toxic than the present confocal model, allowing the cell to be observed for much longer. Moreover, it is a powerful technology based on extensive science and engineering, but we simplify it for users so that biologists with little expertise may use it. That could eventually help scientists unlock the mystery of how certain diseases were formed and developed at a cellular level. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

Advanced live-cell imaging technology and equipment are expensive, lack of skilled professionals and stringent government approvals for types of equipment and software are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The live cell imaging market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 researchers employ remote live-cell imaging to monitor and investigate virus-infected cells without entering the lab. This saves time and reduces the risks involved with the COVID-19 study. Current cell-based assays for examining SARS-CoV-2 cell entrance involve either an actual virus or spike-bearing pseudotyping viruses, which is time-consuming and necessitates biosafety facilities and multistep experimental techniques. This has significantly hampered relevant investigations, particularly high-throughput screening experiments. Several researchers have developed a fluorescent SARS-CoV-2 entry probe that can be visualized and quantified using live-cell imaging to implement an ideal system for high-throughput screening SARS-CoV-2 entry inhibitors in virus-free environments supporting antibody and vaccine development. SARS-CoV-2, the virus that produces COVID-19, is being studied by several worldwide researchers. Researchers can utilize live-cell imaging methods, such as advanced microscopy equipment, during the viral study to analyze cellular activities. Virology-based research necessitates the processing of vast amounts of data to generate vaccinations.

In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Equipment segment is expected to hold the largest market share in live cell imaging market

The equipment segment is expected to dominate in 2021. The segment is further sub-segmented into standalone systems, microscopes, cell analyzers, and image capturing devices. In this, Equipment or devices that can function independently of other hardware and are not integrated into another device are called standalone systems. The extensive use of these systems in live-cell imaging and the rising emphasis on research and technological development are the primary reasons driving the segment's growth. Moreover, according to a February 2022 update, TGen and Deepcell partnered to classify and isolate sick cells using artificial intelligence-based technology. Deepcell's AI-powered technology transforms cell morphology into a quantitative and high throughput marker for use in research and a novel independent way to supplement existing molecular procedures. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global live cell imaging market

In 2021, North America accounted for the highest revenue share. The rising geriatric population, significant commitment and funding available for live-cell imaging research, high adoption of innovative treatments, the presence of large pharmaceutical corporations and prominent research institutes, as well as their active involvement in the development and commercialization of novel, enhanced live-cell imaging systems in the region are some of the factors the market is expected to boost in the forecast period. For instance, PHC Corporation of North America announced cooperation with SCREEN Holdings Co., Ltd. on September 21, 2021, to market and distributed the SCREEN Cell3iMager family of live-cell imaging equipment in North America. Moreover, biopharmaceutical companies invested more than a trillion dollars in research and development over the last decade, including a record-breaking year in 2020, when PhRMA member companies invested approximately USD 91 billion in research and development. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the live cell imaging market are PerkinElmer Inc, Live Cell Instruments, Zeiss Group, Axion BioSystems, Inc, Becton, Dickinson and Company, CYTENA, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Agilent Technologies , Cytiva.

PerkinElmer Inc.:

Overview:

PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers, and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. The company has a dedicated team of more than 16,000 and collaborates closely with commercial, government, academic, and healthcare customers to deliver reagents, assays, instruments, automation, informatics, and strategic services that accelerate workflows, deliver actionable insights, and support improved decision making. The company serves customers in 190 countries and is a component of the S&P 500 index.

Product Portfolio:

MuviCyte Live-Cell Imaging Kit: The MuviCyte live-cell imaging system works inside your cell-culture incubator, allowing you to keep your cells in ideal conditions while performing various experiments in different culture containers. The MuviCyte live-cell imaging package includes a live-cell imaging apparatus as well as 4x, 10x, and 20x objective lenses, a PC, and a monitor.

The global live cell imaging market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.